As a type of highly heterogeneous malignancy, human breast cancer could be mainly divided into four molecular subtypes characterized by different gene expression patterns of several biomarkers, including estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) [2]. This evidence concerns the gene ESR1 and breast cancer.